Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-17 4:01 pm Purchase |
2022-10-06 | 13G | Arcus Biosciences, Inc. RCUS |
PFM Health Sciences, LP | 3,933,233 5.500% |
502,223 (+14.64%) |
Filing History |
| 2022-05-09 3:23 pm Purchase |
2022-04-30 | 13G | Arcus Biosciences, Inc. RCUS |
BLACKROCK INC BLK |
7,967,677 11.100% |
3,837,748 (+92.93%) |
Filing History |
| 2022-03-14 4:48 pm Purchase |
2022-03-03 | 13G | Arcus Biosciences, Inc. RCUS |
BIOTECHNOLOGY VALUE FUND L P | 3,960,948 5.600% |
1,208,726 (+43.92%) |
Filing History |
| 2022-02-14 4:02 pm Purchase |
2021-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
EcoR1 Capital LLC | 5,523,358 7.900% |
951,311 (+20.81%) |
Filing History |
| 2022-02-14 12:38 pm Purchase |
2021-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
PFM Health Sciences, LP | 3,431,010 4.900% |
57,550 (+1.71%) |
Filing History |
| 2022-02-14 12:30 pm Sale |
2021-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
GV 2016, L.P. | 2,563,441 3.650% |
-2,486,345 (-49.24%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
BLACKROCK INC BLK |
4,129,929 5.900% |
758,628 (+22.50%) |
Filing History |
| 2021-07-19 5:16 pm Purchase |
2021-07-09 | 13G | Arcus Biosciences, Inc. RCUS |
EcoR1 Capital LLC | 4,572,047 6.400% |
4,572,047 (New Position) |
Filing History |
| 2021-03-09 6:33 pm Purchase |
2021-02-28 | 13G | Arcus Biosciences, Inc. RCUS |
BLACKROCK INC BLK |
3,371,301 4.800% |
116,210 (+3.57%) |
Filing History |
| 2021-02-16 4:43 pm Sale |
2020-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
Boxer Capital LLC | 2,084,883 3.200% |
-937,508 (-31.02%) |
Filing History |
| 2021-02-16 4:10 pm Unchanged |
2020-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
PFM Health Sciences, LP | 3,373,460 5.200% |
0 (Unchanged) |
Filing History |
| 2021-02-02 4:51 pm Sale |
2021-01-31 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC GILD |
22,723,156 35.000% |
-6,775,268 (-22.97%) |
Filing History |
| 2021-02-02 2:56 pm Purchase |
2020-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
BLACKROCK INC BLK |
3,255,091 5.000% |
763,110 (+30.62%) |
Filing History |
| 2020-12-10 5:16 pm Sale |
2020-02-04 | 13G | Arcus Biosciences, Inc. RCUS |
BIOTECHNOLOGY VALUE FUND L P | 2,752,222 4.200% |
-826,801 (-23.10%) |
Filing History |
| 2020-11-09 4:01 pm Purchase |
2020-10-29 | 13G | Arcus Biosciences, Inc. RCUS |
PFM Health Sciences, LP | 3,373,460 5.200% |
3,373,460 (New Position) |
Filing History |
| 2020-11-04 4:52 pm Sale |
2020-08-20 | 13G | Arcus Biosciences, Inc. RCUS |
The Column Group II, LP | 0 0.000% |
-3,540,850 (Position Closed) |
Filing History |
| 2020-10-15 4:42 pm Sale |
2020-10-13 | 13D | Arcus Biosciences, Inc. RCUS |
Jaen Juan C. | 1,894,967 2.920% |
-1,144,499 (-37.65%) |
Filing History |
| 2020-07-17 2:01 pm Purchase |
2020-07-08 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC GILD |
29,498,424 35.000% |
29,498,424 (New Position) |
Filing History |
| 2020-06-09 4:32 pm Sale |
2020-05-31 | 13G | Arcus Biosciences, Inc. RCUS |
BLACKROCK INC BLK |
2,491,981 4.400% |
-516,781 (-17.18%) |
Filing History |